The (11;14)(q13;q32) translocation in multiple myeloma: A morphologic and immunohistochemical study

American Journal of Clinical Pathology

Volumn 113, Issue 6, 2000, Pages 831-837

  Hoyer, J D ^a   Hanson, C A ^a   Fonseca, R ^a   Greipp, P R ^a   Dewald, G W ^a   Kurtin, P J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cyclin D1; Immunohistochemistry; Multiple myeloma; t(11; 14)(q13; q32)

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHROMOSOME 11; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

EID: 0034502263     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4W8E-8F4K-BHUP-UBE7     Document Type: Article

References (49)

1. Chronic myelogenous leukemia: A concise update
2. The molecular biology of chronic myeloid leukemia
3. Acute promyelocytic leukemia: From genetics to treatment
4. The t(15;17) translocation in acute promyelocytic leukemia
5. Chromosome 14 translocations in non-Burkitt lymphomas
6. Multiple recurrent genomic defects in follicular lymphoma: A possible role model for cancer
7. Human C-MYC oncogene is located in the region of chromosome 8 that is translocated in Burkitt lymphoma cells
8. bcl-1, t(11;14), and mantle cell-derived lymphomas
9. t(11;14)(q13;q32) in B-cell lymphomas (intermediately differentiated lymphocytic and follicular): A report of four cases
10. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data
11. Mantle cell lymphoma: An entity comes of age
12. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation
13. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster
14. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas
15. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas
16. PRAD1 gene over-expression in mantle cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma
17. Mantle cell lymphoma: A lymphoproliferative disorder associated with aberrant function of the cell cycle
18. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma
19. Bcl-1/cyclin D1 in malignant lymphoma
20. Cyclin D1 overexpression in malignant lymphoma
21. Cyclin D1 and human neoplasia
22. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the bcl-1/cyclin D1 gene
23. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma
24. Cyclin D1 expression in non-Hodgkin's lymphomas: Detection by immunohistochemistry
25. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow
26. Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders
27. Cytogenetic study in multiple myeloma
28. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis
29. Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: Correlation with survival
30. Comparison of chromosome analysis and bcl-1 rearrangement in a series of patients with multiple myeloma
31. Correlations between karyotype and cytologic findings in multiple myeloma
32. Cytogenetics and molecular genetics in multiple myeloma
33. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines
34. The t(11;14)(q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene
35. Molecular analysis of 11q13 breakpoints in multiple myeloma
36. Cyclin D1 protein in multiple myeloma and plasmacytoma: An immunohistochemical study using fixed paraffin-embedded tissue sections
37. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies
38. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry
39. Cytogenetic studies in malignant lymphoma: Possible role in staging studies
40. Multiple myeloma and the translocation t(11;14)(q13;q32): A report on 13 cases
41. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotypic abnormalities
42. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants
43. Plasmablastic morphology: An independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group
44. 2 Translocations t(11;14) and t(1;6), in a patient with plasma cell leukaemia and 2 populations of plasma cells
45. Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia
46. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia
47. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
48. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse free survival after transplantation